We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Sensors Developed to Detect Disease Markers in Breath

By LabMedica International staff writers
Posted on 30 May 2017
A small, thin square of an organic plastic that can detect disease markers in breath or toxins in a building's air could soon be the basis of portable, disposable sensor devices. More...
A device that monitors ammonia in breath, a sign of kidney failure, has been demonstrated.

Different groups of scientists have tried using organic semiconductors for gas sensing, but the materials were not sensitive enough to detect trace levels of disease markers in breath. One group has realized that the reactive sites were not on the surface of the plastic film, but buried inside it.

Bioengineers at the University of Illinois Urbana-Champaign focused on ammonia as a marker for kidney failure. Monitoring the change in ammonia concentration could give a patient an early warning sign to call their doctor for a kidney function test. The material they chose is highly reactive to ammonia but not to other compounds in breath, but by changing the composition of the sensor, they could create devices that are tuned to other compounds. For example, the scientists have created an ultrasensitive environmental monitor for formaldehyde, a common indoor pollutant in new or refurbished buildings.

By introducing tunable nanopores (50–700 nm) to organic semiconductor thin films enhances their reactivity with volatile organic compounds by up to an order of magnitude, while the surface-area-to-volume ratio is almost unchanged. Mechanistic investigations show that nanopores grant direct access to the highly reactive sites otherwise buried in the conductive channel of the transistor. The high reactivity of nanoporous organic field-effect transistors leads to unprecedented ultrasensitive ultrafast, selective chemical sensing below the 1 ppb level on a hundred millisecond time scale, enabling a wide range of health applications.

Ying Diao, PhD, an assistant professor and lead investigator said, “We would like to be able to detect multiple compounds at once, like a chemical fingerprint. It's useful because in disease conditions, multiple markers will usually change concentration at once. By mapping out the chemical fingerprints and how they change, we can more accurately point to signs of potential health issues.” The study was published on May 2, 2017, in the journal Advanced Functional Materials.


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated Microscope
dIFine
New
Drug Test Kit
DrugCheck 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.